BIOHAVEN LTD (BHVN)

VGG1110E1079 - Common Stock

50.04  -0.84 (-1.65%)

After market: 50.04 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

BIOHAVEN LTD

NYSE:BHVN (11/4/2024, 7:00:00 PM)

After market: 50.04 0 (0%)

50.04

-0.84 (-1.65%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month40.21%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap4.92B
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

BHVN Daily chart

Company Profile

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company is headquartered in New Haven, Connecticut and currently employs 239 full-time employees. The company went IPO on 2022-09-23. The firm is focused on the discovery, development, and commercialization of treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its clinical and preclinical programs include Kv7 ion channel modulation for epilepsy and mood disorders; extracellular protein degradation for immunological diseases; Transient Receptor Potential Melastatin 3 (TRPM3) antagonism for migraine and neuropathic pain; Tyrosine Kinase 2/Janus Kinase 1 (TYK2/JAK1) inhibition for neuroinflammatory disorders; glutamate modulation for obsessive-compulsive disorder (OCD) and spinocerebellar ataxia (SCA); myostatin inhibition for neuromuscular and metabolic diseases, including spinal muscular atrophy (SMA) and obesity; and antibody recruiting, bispecific molecules and antibody drug conjugates (ADCs) for cancer. The Troriluzole is a new chemical entity (NCE) and tripeptide prodrug of the active metabolite, riluzole.

Company Info

BIOHAVEN LTD

215 Church Street

New Haven CONNECTICUT 06510

P: 12034040410

CEO: Vlad Coric

Employees: 239

Website: https://www.biohaven.com/

BHVN News

News Image3 days ago - Market News VideoNotable Friday Option Activity: BHVN, GETY, AFRM
News Image12 days ago - Market News VideoTop Buys by Directors: Childs's $1000K Bet on BHVN
News Imagea month ago - Investor's Business DailyScholar Rock Catapults By Triple Digits On Final-Phase Win In Spinal Muscular Atrophy

The company is hoping to treat patients with spinal muscular atrophy, a muscle-wasting disease.

News Imagea month ago - Market News VideoBiohaven Larger Than S&P 500 Component Deckers Outdoor
News Imagea month ago - Market News VideoNoteworthy Thursday Option Activity: U, BHVN, RKT
News Imagea month ago - Market News VideoTop Buys by Top Brass: Chief Executive Officer Coric's $1000K Bet on BHVN

BHVN Twits

Here you can normally see the latest stock twits on BHVN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example